Agalsidase beta (Genetical Recombination) for Injection 35mg/Vial 60cases,and 17 other contracts<br />

2026-11-03

Official in charge of disbursement of the procuring entity : Dou Yuji, The Obligating Officer Director of Finance Department, University of Fukui Classification of the products to be procured : Nature and quantity of the products to be purchased : A Agalsidase beta (Genetical Recombination) for Injection 35mg/Vial 60cases B Axicabtagene ciloleucel 1bag 1case C Atezolizumab (Genetical Recombination) Injection 1,200mg20mL/Vial 248cases D Inotuzumab ozogamicin (Genetical Recombination) for Injection 1mg/Vial 24cases E Emicizumab (Genetical Recombination) Injection 150mg1mL/Vial 24cases F Onasemnogene abeparvove Patient Dose 1case G Satralizumab (Genetical Recombination) Kit 120mg1mL/Syringe 50cases H Cetuximab (Genetical Recombination) Injection 100mg20mL/Vial 1,506cases Ⅰ Teprotumumab (Genetical Recombination) for Injection 500mg/Vial 26cases J Pabinafus Alfa (Genetical Recombination) for Injection 10mg/Vial 460cases K Human (autologous) Bone Marrow-Derived mesenchymal stem cells Dose 2cases L Faricimab (Genetical Recombination) Kit 6mg0.05mL/Syringe 352cases M Vutrisiran Sodium Kit 25mg0.5mL/Syringe 12cases N Pegfilgrastim (Genetical Recombination) Kit 3.6mg0.36mL/Syringe 388cases O Pertuzumab (Genetical Recombination)･Trastuzumab (Genetical Recombination)･Vorhyaluronidase alfa (Genetical Recombination) Injection 10mL/Vial 258cases P Polatuzumab Vedotin (Genetical Recombination) for Injection 30mg/Vial 322cases Q Ravulizumab (Genetical Recombination) Injection 1100mg11mL/Vial 18cases R Remdesivir for Injection 100mg/Vial 440cases Delivery period : From April, 202 through 3 March, 202 Delivery place : University of Fukui Hospital Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : A not come under Article of the Regulation concerning the Contract for University of Fukui Furthermore, minors, Person under Conservatorshi or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause, B have the Grade A, Grade B or Grade C qualification during fiscal 202 in the Tokai・Hokuriku area in sales of product for participating in tenders by Single qualification for every ministry and agency, C prove to have obtained either the first-class license or the third-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices, D prove to have the ability to deliver the products, required by this notice, on the date and the place specified by the Obligating Officer, E not be currently under a suspension of business order as instructed by The Obligating Officer. Time limit of tender : 1 : 0 1 March, 202 Contact point for the notice : Akihiro Igarashi, Procurement Section, Accounting Division, Finance Department, University of Fukui, 23- Matsuokashimoaizuki Eiheiji-cho Yoshida-gun Fukui 910-119 Japan, TEL 0776-61-311 ex. 314 ⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.

Japan

2026-03-26